Skip to content

R&D at other companies

Abbott logo
AbbottABT
$767M+7.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$249M+7.3%
TFX
TeleflexTFX
$44.39M+75.5%
Stryker logo
StrykerSYK
$413M+2.0%
Edwards Lifesciences logo
Edwards LifesciencesEW
$263.3M+3.4%
Medtronic logo
MedtronicMDT
$671M-1.9%

Segments

By segment

See full
Single Reportable$22.61M

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's R&D?
Merit Medical Systems (MMSI) reported R&D of $22.61M in Q1 2026.
How has Merit Medical Systems's R&D changed year-over-year?
Merit Medical Systems's R&D increased by 0.6% year-over-year, from $22.48M to $22.61M.
What is the long-term trend for Merit Medical Systems's R&D?
Over 4 years (2021 to 2025), Merit Medical Systems's R&D has grown at a 8.1% compound annual growth rate (CAGR), from $71.25M to $97.35M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.